WuXi PharmaTech Dodges Securities Suit
A New York federal judge tossed a proposed class action Wednesday that alleged pharmaceutical research and development company WuXi PharmaTech misled investors by not disclosing a strategy to spin off three...To view the full article, register now.
Already a subscriber? Click here to view full article